In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 232 for your search:
Drug:  docetaxel
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GENTA-GN304, NCI-G01-2046, UCLA-0301058, NCT00030641

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1594, E1594

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067211, S9916, U10CA032102, SWOG-S9916, CLB-99808, NCCTG-S9916, NCT00004001

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID99-242, P30CA016672, MDA-ID-99242, AVENTIS-MDA-ID-99242, NCI-1691, CDR0000068408, 1691, NCT00008411

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: AVENTIS-TAX-GMA-302, UCLA-0102006, BCIRG-006, UAB-0106, UAB-F010326012, NCI-G01-1978, NCT00768092

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, NCI-2009-00009, 3410, NCT00024167

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654

8.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000069417, NCCTG-N01C9, NCI-P02-0226, N01C9, NCT00040885

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000257580, P30CA016042, UCLA-0109024, BCIRG-007, ROCHE-UCLA-0109024, GENENTECH-UCLA-0109024, NCI-G02-2116, NCT00047255

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: LILY1503, P30CA043703, CASE-CWRU-LILY-1503, LILLY-B9E-US-S245, CASE-1503, NCT00074204

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02956, E1302, ECOG-E1302, U10CA021115, NCT00088907

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: NSABP B-38, U10CA012027, NCT00093795

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: DFCI 04-006, P30CA006516, CDR0000393548, AVENTIS-DFCI-04006, PARADIGM TRIAL, NCT00095875

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02814, CDR0000427290, CALGB-90401, P30CA014236, U10CA031946, ECOG-90401, NCT00110214

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000439434, S0421, U10CA032102, SWOG-S0421, NCT00134056

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0521, CDR0000462375, NCI-2009-00728, NCT00288080

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00509, ECOG-E1505, CDR0000475774, E1505, U10CA180820, U10CA021115, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805

18.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000491071, NCCTG-N05C3, N05C3, NCT00363129

19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NSABP B-40, NCT00408408

20.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000617081, S0715, U10CA037429, SWOG-S0715, NCT00775645

21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000636895, CALGB-30506, NCT00863512

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-03041, S0023, U10CA032102, CDR0000068706, SWOG-S0023, CAN-NCIC-BR15, NCCTG-S0023, BR15, NCT00020709

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: NSABP B-27, CDR0000064521, NCT00002707

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: NSABP B-30, CDR0000066914, NCT00003782

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066563, E2197, CLB-49802, NCCTG-E2197, SWOG-E2197, NCT00003519
1     
New Search